Inflammatory Disorders

1. Front Matter

   Pages i-x

   PDF

2. Inhaled Corticosteroids Increase Siglec-5/14 Expression in Sputum Cells of COPD Patients

   • P. Wielgat, R. M. Mroz, A. Stasiak-Barmuta, P. Szepiel, E. Chyczewska, J. J. Braszko et al.

   Pages 1-5

3. Tregs and HLA-DR Expression in Sputum Cells of COPD Patients Treated with Tiotropium and Formoterol

   • A. Holownia, P. Wielgat, A. Stasiak-Barmuta, A. Kwolek, P. Jakubow, P. Szepiel et al.

   Pages 7-12

4. Inhalation of Macrolides: A Novel Approach to Treatment of Pulmonary Infections

   • R. Siekmeier, T. Hofmann, G. Scheuch

   Pages 13-24

5. Influence of Denture Plaque Biofilm on Oral Mucosal Membrane in Patients with Chronic Obstructive Pulmonary Disease

   • D. Przybyłowska, E. Mierzwińska-Nastalska, R. Rubinsztajn, R. Chazan, D. Rolski, E. Swoboda-Kopeć

   Pages 25-30

6. Biophysical Activity of Animal-Derived Exogenous Surfactants Mixed with Rifampicin

   • M. Kolomaznik, A. Calkovska, E. Herting, G. Stichtenoth

   Pages 31-39

7. Organic Changes in the Central Nervous System in Children on Chronic Inhaled Corticosteroid Therapy

   • M. Michalczuk, A. J. Sybilski, A. Piliszek, J. Walecki

   Pages 41-45

8. Stem Cell Experiments Moves into Clinic: New Hope for Children with Bronchopulmonary Dysplasia

   • K. Pawelec, D. Gładysz, U. Demkow, D. Boruczkowski

   Pages 47-53

9. Soluble Ligand CD40 and Uric Acid as Markers of Atheromatosis in Patients with Obstructive Sleep Apnea

   • M. Kosacka, A. Brzecka, P. Piesiak, A. Korzeniewska, R. Jankowska

   Pages 55-60

10. Carotid Artery Intima-Media Thickness in Hypertensive Patients with Obstructive Sleep Apnea

    • M. Kostrzewska, T. Piorunek, K. Hoffmann, H. Batura-Gabryel, S. Cofta

    Pages 61-66

11. Back Matter

    Pages 67-67

    PDF

The mechanistic basis of chronic inflammation remains unclear. The research sheds new light on the immune cells expressing the activation markers HLA-DR and regulatory T cells (Tregs) and the cells expressing Siglec receptors as being key players in the immune system responsiveness to antigens and thus in lung tissue damage of chronic inflammation. The results help understand the mechanisms of action of common drugs used in COPD, such as formoterol, tiotropium, or corticosteroids, and point to novel drug targets. The chapters also deal with brain damaging effects, by far unrecognized, of inhaled corticosteroid therapy, a time-proven management of chronic inflammatory airway conditions; asthma being a case in point. Novel methods, likely less producing side effects, of macrolide antibiotics administration by inhalation are discussed, emphasizing not only bacteriostatic but also anti-inflammatory action.

• Aerosol
• Antibiotics
• Atherosclerosis
• Cardiovascular risk factors
• Corticosteroids
• Denture stomatitis
• Hypertension
• Lung diseases
• Mesenchymal stem cell
• Prematurity
• Pulmonary surfactant
• Respiratory pathogens

• Institute of Psychology, Opole University, Poland

  Mieczyslaw Pokorski

Policies and ethics